Gatifloxacin Catalog No.:M10548-10 Echinacoside inhibits breast cancer cells

Echinacoside inhibits breast cancer cells by suppressing the Wnt/β-catenin signaling pathway

Akintunde JK

PubMed PMID: 24434211

vitro=61 mL/min•kg)

The ability of CEP-33779 to suppress growth of colorectal tumors by inhibiting the IL-6/JAK2/STAT3 signaling suggests a potential therapeutic utility of JAK2 inhibitors in multiple tumors types

Gatifloxacin Catalog No.:M10548-10 Echinacoside inhibits breast cancer cellsGatifloxacin is an antibiotic of the fourth generation fluoroquinolone family that inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Gatifloxacin is a fluoroquinolone antibiotic, with potent activity against Gram negative and Gram positive bacteria. Bristol Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections. Allergan produces it in eye drop formulation under